Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2239-2025

Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System Software Recall

Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System Software

FDA recall Class II

Ongoing

FDA lists this Class II recall for Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System Software. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2239-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 17, 2025
FDA report date
Aug 13, 2025
Quantity in commerce
149 Serial Numbers
Distribution
See key details
FDA cause
Software change control

What is being recalled?

Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System Software

Affected model & UDI checker

Search the exact identifiers published for Z-2239-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedPinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System SoftwareCheck source notice00884838103566
FDA code information

Software Version Number: 18.0.5/UDI: (01)00884838103566

View the original FDA recall notice

Why was this product recalled?

Due to software issue, Radiation Therapy Planning system may provide incorrect dataset calculations when performing the "Stopping Power Ratio" (SPR) ,

What actions did Philips Medical Systems (Cleveland) Inc take?

On July 17, 2025, Philips issued a "Urgent Medical Device Correction" Notification to affected consignees. Philips asked consignees to take the following actions: 1. You may continue to use your system(s) in accordance with the intended use and by following the recommendations below. 2. To prevent the issue from occurring, when using SPR generation, always verify data sets are from same acquisition and matching reconstruction parameters. 3. Ensure that relevant clinical staff, including physicians, physicists, and dosimetrists, are informed about the potential for incorrect dataset calculations due to mixing of data sets 4D CT spectral and SPR generation. 4. Circulate this notice to all users of this device so that they are aware of the potential issue. Please retain this letter with your system(s) until a solution is installed on your system; ensure the letter is in a place likely to be seen/viewed. 5. Please complete and return the attached response form to Philips promptly and no later than 30 days from receipt of this letter via email to: [email protected]

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology